Sorted By:



PhRMA  |  From PhRMA

click here for even more information on 340B.

340B Spotlight: 340B hospitals continue to benefit from consolidation at expense of patients

PhRMA  |  Blog Post

This markup becomes even more egregious, 79 percent, if the hospital was able to acquire the drug at the 340B discounted price.

340B Drug Discount Program Pocket Card

PhRMA  |  Fact Sheet

Clinics eligible for the 340B program as part of a federal grant program are required to reinvest any additional resources into services for the vulnerable communities they serve, while current rules allow hospitals participating in the program to profit by reselling discounted medicines with no requirement to ensure patients benefit from the discounts.

340B Then & Now

PhRMA  |  Graphic

340B Spotlight: A look at 340B eligibility and charity care

PhRMA  |  Blog Post

Stricter 340B eligibility criteria are needed to address the market distorting effects of the 340B program.

340B Spotlight: Retail pharmacies continue to expand the 340B program

PhRMA  |  Blog Post

Currently, there are no rules regarding how covered entities use revenue from the 340B program, and there is no obligation that patients who cannot afford their medicines receive the 340B discount when they try to fill a prescription at a contract pharmacy.

340B Spotlight: Trends in shifting site of care

PhRMA  |  Blog Post

It is time for policymakers to reform 340B program eligibility for hospitals and child sites to be consistent with Congress’ original intent for the 340B program, which was designed to support care provided in true safety-net hospitals.

340B Spotlight: Despite access to discounts, many 340B hospitals fail to comply with ACA charity care requirements

PhRMA  |  Blog Post

For more on 340B, check out our latest 340B Spotlight posts.

340B Spotlight: Audit findings show importance of increased oversight of 340B program

PhRMA  |  Blog Post

Learn more about the 340B program at

Legislative and Regulatory History of the Evolution of 340B Program

PhRMA  |  Fact Sheet

The 340B program was created by Congress in 1992 to help vulnerable or uninsured patients access prescription medicines at safety net facilities.

340B Spotlight: Program continues to grow with no end in sight

PhRMA  |  Blog Post

Presented at: 340B Coalition Winter Conference.

340B Program in urgent need of expanded Congressional and administrative oversight, reform

PhRMA  |  Press Release

As additional evidence that the program has expanded beyond true safety net hospitals, the analysis revealed that about one-fifth of 340B hospitals provide 80 percent of all charity care delivered by 340B hospitals.

Trends in 340B Drug Purchases and Percent of Total Population without Prescription Drug Coverage

PhRMA  |  Graphic

Drug purchases through the 340B program will continue to rise, at the same time the share of the population without prescription drug coverage will nearly drop in half.

PhRMA Special 301 Submission 2017

PhRMA  |  Policy Paper

The Special 301 statute calls upon the Office of the United States Trade Representative (USTR) to address in its review foreign country practices that deny fair and equitable market access to U.S. persons that rely upon intellectual property (IP) protection.

PhRMA Statement on 2016 Special 301 Report

PhRMA  |  Press Release

PhRMA members welcome USTR’s decision to maintain India on the Priority Watch List and the emphasis the Special 301 Report places on achieving substantive and measurable results.

340B Percent of Pharmaceutical Sales

PhRMA  |  Graphic


PhRMA Statement on 2017 Special 301 Report

PhRMA  |  Press Release

“The Special 301 Report is an essential tool to engage America’s trading partners on intellectual property and market access challenges in overseas markets that are harming American innovators, patients, and workers.

340B Mega Guidance

PhRMA  |  Blog Post

Subscribe to industry alerts for issues such as 340B, access to medicines & more.

How 340B Discounts Work

Chartpack  |  From Our Network

Manufacturers provide 340B hospitals with discounted medicines, who then provide the medicines to patients, and then insurers reimburse the hospitals at a full negotiated rate and the hospital keeps the difference as profit.

340B: Past and Present

Chartpack  |  From Our Network

When it was created in 1992, 340B was envisioned as a small program however insufficient guidance, historically weak oversight, and other factors have led to dramatic program growth, driven by the participation of large hospitals in the 340B program.

PhRMA Statement on AARP Prescription Drug Report

PhRMA  |  Press Release

Washington, D.C. (November 16, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today:  “In AARP’s skewed view of the world, medicines are always looked at as a cost and never seen as a sa...

340B Spotlight: A Look at 340B Purchases

PhRMA  |  Blog Post

By 2019, the Berkeley Research Group projects the 340B program will account for 8.0 percent of sales.

340B Spotlight: A lack of charity care among 340B hospitals

PhRMA  |  Blog Post

  For more check out our chart pack or stay up-to-date on the latest 340B news with our 340B Spotlight posts.

How 340B discounts work

PhRMA  |  Blog Post

Learn more about 340B at and stay tuned to 340B Spotlight posts for more on this important program and the changes needed to ensure it benefits those it was intended to help.

New Analysis: Who Benefits from Contract Pharmacy Arrangements in 340B Program?

PhRMA  |  Blog Post

4] Alliance for Integrity and Reform of 340B, "Unfulfilled Expectations: An analysis of charity care provided by 340B hospitals," Spring 2014 (Available at:

You have reviewed the first 25 results out of 358. Each page contains 25 results. You're on page 1.

prev 1 2 3 4 5 6 next